| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 27.10. | Adalvo Acquires Romiplostim Biosimilar Program from Enzene | ||
| 27.10. | Aptar Pharma, Stevanato Group Partner on Pre-Filled Syringe Configuration Assessments | ||
| 27.10. | Teva Completes Acquisition of BioXcel Assets, Expands Neuroscience Pipeline | ||
| 27.10. | AstraZeneca and Daiichi Sankyo's Enhertu Gets EU Nod for Residual Treatment in HER2+ Early Breast Cancer | ||
| 27.10. | Humanitas Global Health Launches at AAPS PharmSci 360 | ||
| 27.10. | DFE Pharma Appoints Peter Rose as New Chief Operating Officer | ||
| 26.10. | Regeneron Extends BARDA Deal for Ebola Treatment Supply for $270M Through 2031 | ||
| 26.10. | FDA Expands Approval of Pfizer's Talzenna Plus Xtandi for Earlier Prostate Cancer Treatment | ||
| 26.10. | Aurigene, Dr. Reddy's, Innoviva Specialty Therapeutics and GARDP Recognized at CPHI | ||
| 23.10. | Meissner Celebrates Ribbon-Cutting and Groundbreaking for Two Georgia Facilities | ||
| 23.10. | Roche Licenses Zymeworks' ZW209 Cancer Therapy | ||
| 22.10. | eGenesis Picks Daniel Leblanc as New Chief Manufacturing and Supply Officer | ||
| 22.10. | Antogen Opens Oklahoma City Laboratory to Help Scale Biopharma Services | ||
| 22.10. | ProBio Successfully Completes Pre-Approval Inspection of China Biologics Manufacturing Facility | ||
| 22.10. | Ardena Invests in New Compaction Simulator in Ghent | ||
| 22.10. | MVIC, Upperton Launch Integrated Drug Development Pathway | ||
| 22.10. | Resyca, Cyrano Report Positive Phase 2 Smell Loss Results | ||
| 22.10. | Recipharm Expands Sterile Manufacturing in Portugal | ||
| 22.10. | LGM Pharma Acquires Sannova Analytical | ||
| 21.10. | Eppendorf, BioLabs Expand Collaboration to New Munich Site | ||
| 21.10. | Touchlight CEO Karen Fallen Stepping Down, Will Downie Appointed as Interim | ||
| 21.10. | Zylidac Bio, Prolific Machines Partner to Scale Next-Gen Biologics | ||
| 21.10. | ESTEVE CDMO Invests $80M in China to Expand Global Manufacturing Footprint | ||
| 20.10. | ScionxBio Partners with Sanofi on Extended Exposure Versions of mRNA Candidates | ||
| 20.10. | AstraZeneca Partners with Oracle to Connect AI Capabilities to Healthcare Innovations |